Published in MBio on April 12, 2016
Type I Interferons in Newborns-Neurotoxicity versus Antiviral Defense. MBio (2016) 0.75
Treatment of perinatal viral infections to improve neurologic outcomes. Pediatr Res (2016) 0.75
Spontaneous activation of a MAVS-dependent antiviral signaling pathway determines high basal interferon-β expression in cardiac myocytes. J Mol Cell Cardiol (2017) 0.75
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science (1998) 7.89
Neonatal adaptive immunity comes of age. Nat Rev Immunol (2004) 5.31
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A (2000) 3.51
Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science (2013) 3.10
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron (2011) 2.83
A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med (1999) 2.62
ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J Virol (1994) 2.30
Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol (2003) 1.48
Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1. Proc Natl Acad Sci U S A (2009) 1.16
Kinetic profile of the transcriptome changes induced in the choroid plexus by peripheral inflammation. J Cereb Blood Flow Metab (2009) 1.12
Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J Virol (2010) 1.10
Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol (2011) 1.09
Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res (2013) 1.07
Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev (2014) 1.03
Reduced ventricular proliferation in the foetal cortex following maternal inflammation in the mouse. Brain (2011) 1.03
Expression of Toll-like receptors in the developing brain. PLoS One (2012) 0.93
Derivation of primary choroid plexus epithelial cells from the mouse. Methods Mol Biol (2010) 0.93
Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1. J Virol (2015) 0.92
Functional genomics reveals an essential and specific role for Stat1 in protection of the central nervous system following herpes simplex virus corneal infection. J Virol (2011) 0.92
Neurotropism of herpes simplex virus type 1 in brain organ cultures. J Gen Virol (2006) 0.92
Cell trafficking through the choroid plexus. Cell Adh Migr (2012) 0.90
Expression of nectin-1 in normal and herpes simplex virus type 1-infected murine brain. Appl Immunohistochem Mol Morphol (2006) 0.89
Differential reliance on autophagy for protection from HSV encephalitis between newborns and adults. PLoS Pathog (2015) 0.82
Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis. Genes Immun (2015) 0.82
HSV targeting of the host phosphatase PP1α is required for disseminated disease in the neonate and contributes to pathogenesis in the brain. Proc Natl Acad Sci U S A (2015) 0.80